Arnatar Therapeutics
Signal active
Organization
Contact Information
Overview
Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.
About
Industries
Medical, Biopharma
Founded
2022
Employees
0
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Arnatar Therapeutics headquartered in United States, North America, operates in the Medical, Biopharma sector. The company focuses on Medical and has secured $1.0B in funding across 16 round(s). Their latest funding round, Seed Round - Arnatar Therapeutics, raised $14.3M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
1
Lead Investors
0
Total Funding Amount
$64.3M
Details
2
Arnatar Therapeutics has raised a total of $64.3M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2024 | Early Stage Venture | 50.0M | ||
| 2022 | Seed | 14.3M |
Investors
Arnatar Therapeutics is funded by 11 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Yijing Capital | - | FUNDING ROUND - Yijing Capital | 50.0M |
| Arnatar Therapeutics | - | FUNDING ROUND - Arnatar Therapeutics | 50.0M |
| Arnatar Therapeutics | - | FUNDING ROUND - Arnatar Therapeutics | 14.3M |
| Apricot Capital | - | FUNDING ROUND - Apricot Capital | 14.3M |
Recent Activity
There is no recent news or activity for this profile.